Showing 2231-2240 of 3223 results for "".
- Alembic Pharmaceuticals Announces FDA Approval for Glaucoma Treatment Acetazolamidehttps://modernod.com/news/alembic-pharmaceuticals-announces-fda-approval-for-glaucoma-treatment-acetazolamide-extended-release-capsules/2476277/India-based Alembic Pharmaceuticals announced that it has received approval from the FDA for its abbreviated new drug application (NDA) for Acetazolamide extended-release capsules, 500 mg. The approved NDA is therapeutically equivalent to the reference listed drug product Diamox Sequels, 500 mg,
- Alcon Debuts iLux MGD Treatment System at SECOhttps://modernod.com/news/alcon-debuts-ilux-mgd-treatment-system-for-personalized-therapy-for-dry-eye-disease-at-seco/2476284/Alcon debuted the iLux MGD Treatment System at the SECO International 2019 annual meeting in New Orleans. The device, which received approval from the FDA in December 2017, helps eye care professionals provide comprehensive, in-office
- Diabetes Eye Exam Frequency in US Is ‘Alarmingly Low’https://modernod.com/news/diabetes-eye-exam-frequency-in-us-is-alarmingly-low/2476288/The frequency of eye exams among insured patients with type 1 and type 2 diabetes in the United States is “alarmingly low,” new research indicates, as reported in Medscape. Findings from an analysis of nationwide IBM Wa
- MacuLogix Hosts Inaugural AMD Speaker Alliancehttps://modernod.com/news/maculogix-hosts-inaugural-amd-speaker-alliance/2476336/MacuLogix hosted the industry’s first AMD Speaker Alliance meeting. The peer-to-peer event was attended by 25 optometric key opinion leaders who are at the front lines of minimizing vision loss due to AMD and other retinal disease. “This meeting is helping us kick off a movement in our pro
- Allergan, Mohawk Tribe Ask for Supreme Court Review of Scrutinized Patent Casehttps://modernod.com/news/allergan-mohawk-tribe-ask-for-supreme-court-review-of-scrutinized-patent-case/2476180/Allergan and the St. Regis Mohawk Tribe aim to continue their legal battle in defense of a controversial patent agreement struck a little over a year ago, appealing last week to the Supreme Court to review a federal appeals court decision which had undermined the deal’s main r
- Johnson & Johnson Vision Launches the UK’s First Free Nationwide Recycling Program for all Contact Lenseshttps://modernod.com/news/johnson-johnson-vision-launches-the-uks-first-free-nationwide-recycling-program-for-all-contact-lenses/2476189/Johnson & Johnson Vision has launched the Acuvue Contact Lens Recycle Program, the UK’s first free nationwide program that enables consumers to easily recycle their contact lenses and the blister and foil packaging after use. The program is available to all soft contact lens wearers reg
- Allergan Announces Positive 3-Month Topline Results from Second Phase 3 Study of Bimatoprost SR Implant for Lowering IOPhttps://modernod.com/news/allergan-announces-positive-3-month-topline-results-from-second-phase-3-study-of-bimatoprost-sr-implant-for-lowering-iop/2476215/Allergan announced positive 3-month topline results from the second pivotal clinical trial of Bimatoprost SR, a first-in-class sustained-release, biodegradable implant for the reduction of IOP in patients with open-angle glaucoma or ocular hypertension. Positive results from the first phase 3 tri
- Oculis In-Licenses Phase 2 Topical Anti-TNF Alpha Antibody From Novartishttps://modernod.com/news/oculis-in-licenses-phase-2-topical-anti-tnf-alpha-antibody-from-novartis/2476220/Oculis has entered into an agreement to in-license a novel topical anti-TNF alpha antibody from Novartis. Terms of the deal were not disclosed. The compound, named LME 636, is based on a proprietary single-chain antibody fragment technology specifically de
- Beaver-Visitec International to Acquire PhysIOL Grouphttps://modernod.com/news/tpg-capital-backs-bvi-to-acquire-physiol-group-sa/2476246/Beaver-Visitec International (BVI) announced it has signed a definitive agreement to acquire PhysIOL Group, a Belgium-based ophthalmic company specializing in the research, development, and manufacture of IOLs, from TA Associates. Financial terms of the transaction were not disclosed.
- Alcon Acquires Tear Film Innovationshttps://modernod.com/news/alcon-announces-acquisition-of-tear-film-innovations/2476248/Alcon announced that it has acquired Tear Film Innovations, maker of the iLux device to treat meibomian gland dysfunction. Financial terms of the deal were not disclosed. Handheld and portable, the iLux enables eye care professionals to directly target a patient’s blocked meibomian